<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02405468</url>
  </required_header>
  <id_info>
    <org_study_id>12 387 02</org_study_id>
    <secondary_id>2013-A00337-38</secondary_id>
    <nct_id>NCT02405468</nct_id>
  </id_info>
  <brief_title>Identification of the Blood Microbiota in Patient Suffering From Myocardial Infraction</brief_title>
  <acronym>FLORINF</acronym>
  <official_title>Identification of the Blood Microbiota in Patient Suffering From Myocardial Infraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators want to compare blood microbiota profile between patients with documented
      coronary lesions and patients free of coronary disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>blood bacterial 16s rDNA bacterial gene concentration</measure>
    <time_frame>12 months</time_frame>
    <description>compare blood bacterial 16s rDNA bacterial gene concentration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood microbiota profile</measure>
    <time_frame>12 months</time_frame>
    <description>compare blood microbiota profile as assessed at all taxonomic levels of interest (genus, family, order, class, phylum)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>lipid profile</measure>
    <time_frame>12 months</time_frame>
    <description>Obtain an accurate lipid profile with a new technic of microelectrophoresis(Lipoprint)</description>
  </other_outcome>
  <other_outcome>
    <measure>functional HDL</measure>
    <time_frame>12 months</time_frame>
    <description>Analyse the functional qualities of the HDL from the serum</description>
  </other_outcome>
  <other_outcome>
    <measure>microARN profile</measure>
    <time_frame>12 months</time_frame>
    <description>Search a microARN profile corresponding to the coronary heart disease</description>
  </other_outcome>
  <other_outcome>
    <measure>Serum Bank and DNA Bank</measure>
    <time_frame>10 years</time_frame>
    <description>Form a Serum Bank and a DNA Bank for potential future analysis guided by microARN research</description>
  </other_outcome>
  <other_outcome>
    <measure>modifications of the blood microbiota</measure>
    <time_frame>12 months</time_frame>
    <description>Analyse modification of the blood microbiota in the case and the control</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">202</enrollment>
  <condition>Coronary Disease</condition>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>case</arm_group_label>
    <description>patients with a myocardial infarction within one month to one year before the inclusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>patients without history of myocardial infarction, free of coronary disease in the view of one of the following test performed within one year before the inclusion : Effort test Echocardiographic stress test Myocardial perfusion scintigraphy Coronarography with &gt;= 2 major cardiovascular risk factors :
Treated hypertension
Treated dyslipidemia
Current smoking
Diabetes mellitus</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood sample
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        case : patients who have had a myocardial infarction within one month to one year before
        the inclusion controls : patients without history of myocardial infarction, free of
        coronary disease in the view of one of the following tests performed within one year before
        the inclusion Effort test Echocardiographic stress test Myocardial perfusion scintigraphy
        Coronarography with &gt;= 2 major cardiovascular risk factors:

          -  Treated hypertension,

          -  Treated dyslipidemia

          -  Current smoking

          -  Diabetes mellitus
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cases : patients who have had a myocardial infarction within one month to one year
             before the inclusion

          -  Controls : patients without history of myocardial infarction, free of coronary disease
             in the view of one of the following tests performed within one year before the
             inclusion :

        Effort test Echocardiographic stress test Myocardial perfusion scintigraphy Coronarography
        with &gt;= 2 major cardiovascular risk factors:

          1. Treated hypertension,

          2. Treated dyslipidemia

          3. Current smoking

          4. Diabetes mellitus

        Exclusion Criteria:

          -  Infectious disease within one week before the inclusion

          -  Immunocompromised patients

          -  Antibiotic treatment within one month before the inclusion

          -  Chronic viral infection

          -  Chronic inflammatory intestinal bowel disease

          -  Renal failure (estimated glomerular filtration rate&lt; 50 ml/min//1.73 m2)

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meyer Elbaz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UHToulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2015</study_first_posted>
  <last_update_submitted>February 14, 2016</last_update_submitted>
  <last_update_submitted_qc>February 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>blood microbiota</keyword>
  <keyword>coronary disease</keyword>
  <keyword>myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

